aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.8990
+0.0883 (10.89%)
At close: Feb 6, 2026, 4:00 PM EST
0.8800
-0.0190 (-2.11%)
After-hours: Feb 6, 2026, 7:58 PM EST
aTyr Pharma Revenue
aTyr Pharma had revenue of $190.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $190.00K, down -19.15% year-over-year. In the year 2024, aTyr Pharma had annual revenue of $235.00K, down -33.43%.
Revenue (ttm)
$190.00K
Revenue Growth
-19.15%
P/S Ratio
463.63
Revenue / Employee
$2,923
Employees
65
Market Cap
88.09M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 235.00K | -118.00K | -33.43% |
| Dec 31, 2023 | 353.00K | -10.03M | -96.60% |
| Dec 31, 2022 | 10.39M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 10.46M | 10.03M | 2,377.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pelthos Therapeutics | 7.41M |
| ImageneBio | 800.00K |
| Precision BioSciences | 698.00K |
| Spruce Biosciences | 697.00K |
| MediciNova | 257.92K |
ATYR News
- 2 days ago - Ethos to Announce Fourth Quarter 2025 Financial Results on February 25, 2026 - GlobeNewsWire
- 4 days ago - The IPO Market Faces a Busy Week. These Stocks Are Making Their Debuts. - Barrons
- 5 days ago - aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis - GlobeNewsWire
- 8 days ago - U.S. IPO Weekly Recap: Trio Of Sizable Listings Underwhelm To Close Out January - Seeking Alpha
- 9 days ago - Ethos Technologies: A Surprisingly Soft Debut - Seeking Alpha
- 10 days ago - Insurance platform Ethos Technologies valued at $1.2 billion in Nasdaq debut - Reuters
- 10 days ago - Ethos Announces Pricing of Initial Public Offering - GlobeNewsWire
- 10 days ago - Ethos Technologies prices US IPO at $19/share, Bloomberg News reports - Reuters